GYRE

Gyre Therapeutics, Inc. $4.56 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
+1.5%
Next 1 month
+4.5%
Seasonality
Bullish window historically
Next 30 days (to Nov 30): +1.9% median, 63% of the last 19 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 9
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.08%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.83 +4.6% · Seasonal tilt -0.0%
$868429/day volume 64% volatility -40% 1-year
52-week range · 1% of the way up · -50% from the high
$4.52$9.14

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 5 days) · EPS est. -0.03.

Biggest pop
+6.9%
Biggest drop
-30.2%

Standard deviation of the close-to-close move over the last 7 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-07 miss -0.06 -0.12 -111.8% +0.2% +4.2% +4.4%
2026-05-07 miss -0.07 -0.10 -36.4% -1.7% -12.1% -12.9%
2026-03-12 beat 0.01 0.05 +368.0% -5.9% -6.2% -18.4%
2025-11-07 beat -0.02 0.03 +250.0% -1.0% -1.8% +8.9%
2025-08-11 miss 0.03 — -100.0% -5.5% +6.9% +6.5%
2025-05-09 miss 0.03 — -100.0% -6.8% +0.5% +19.7%
2025-03-17 miss 0.04 — -100.0% -6.4% -30.2% -22.7%

Not investment advice.